Back to Search

Safety and efficacy of fingolimod in patients with relapsing-remitting multiple sclerosis (FREEDOMS II): a double-blind, randomised, placebo-controlled, phase 3 trial

Paper Details
Authors:
Peter A. Calabresi
Ernst-Wilhelm Radüe
Douglas S. Goodin
Douglas Jeffery
Kottil Rammohan
Anthony T. Reder
Timothy Vollmer
Mark Agius
Ludwig Kappos
Tracy Stites
Bingbing Li
Linda Cappiello
Philipp von Rosenstiel
Fred Lublin
Publication Date: 2014-03-28
Multiple Sclerosis Research StudiesMedicinePathology and Forensic MedicineHealth Sciences
Access Restricted

This paper is not available under open access. The publisher restricts full-text distribution.

You may still be able to access it through your institution, request it directly from the author, or view the abstract and citation details.

External Resources

Paper information is provided by public research databases. Summaries are generated to aid understanding and may not reflect the complete scope of the work. For the authoritative version, please refer to the original publication.